Clinical Trials at

Houston Mind & Brain

A phase III randomized, double-blind, placebo-controlled parallel group trial to examine the efficacy and safety of Iclepertin once daily over 26-week treatment period in patients with schizophrenia (CONNEX-1)

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm

Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Extended-release Capsules as Monotherapy or as Adjunct to SSRI in Adult Subjects with Major Depressive Disorder

For more information on either study, please fill out this form:

We Are Making TMS Therapy More Accessible!

TMS treatments are now 30% OFF

Fill out the fields below to get more information: